The Netherlands has become the latest country to suspend use of the Oxford-AstraZeneca coronavirus vaccine over concerns about possible side effects.
The Dutch government said the move, which will last until at least 29 March, was a precaution.
The Republic of Ireland earlier made a similar decision over reports of blood clotting events in adults in Norway.
The European Medicines Agency (EMA) - who is currently carrying out a review into incidents of blood clots - says the vaccine's benefits continue to outweigh its risks.
